regulatory
confidence high
sentiment negative
materiality 0.70
Clearside Biomedical receives Nasdaq minimum bid price deficiency notice
Clearside Biomedical, Inc.
- Notice received Feb 7, 2025; stock below $1.00 for 30 consecutive business days.
- Company has 180 days (until Aug 6, 2025) to regain compliance.
- To cure, bid price must close at $1.00+ for 10 consecutive business days.
- Options include transfer to Nasdaq Capital Market or reverse stock split.
- Failure to comply may result in delisting; company intends to monitor and seek remedies.